Medical/Pharmaceuticals News & Press Release Distribution

Tairex Launches Virtual Consultation Room, Setting A New Paradigm for AI Medical Services

BEIJING, April 10, 2026 /PRNewswire/ -- Wuxi Tairex Technology Co. Ltd. ("Tairex" or the "Company") today announced the launch of the Virtual Consultation Room for Tairex Agent Hospital, now open to doctors and medical students. Built on Tairex Agent Hospital, a virtual medical world centered on...

2026-04-10 11:28 5971

Tairex Launches Virtual Consultation Room, Setting A New Paradigm for AI Medical Services

ArkBio Completed Dosing of First Cohort in Australian Phase I Trial of Antiviral Drug-Fc Conjugate Drug AK0406

SHANGHAI, April 10, 2026 /PRNewswire/ -- Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") today announced that the first cohort of healthy volunteers has been dosed in a phase I clinical trial of AK0406, a novel long-acting antiviral drug-Fc conjugate (ADFC) drug for influenza infection, follo...

2026-04-10 09:00 6608

Ailux Appoints Maria Belvisi, Ph.D., as Chief Scientific Officer

* Professor Belvisi joins from AstraZeneca, where she served as Senior Vice President, Research & Development, Respiratory & Immunology and built one of the most productive early R&D organizations in global pharma, including leading tozorakimab from preclinical research through Phase 3 investme...

2026-04-10 08:30 6333

Lynk Pharmaceuticals Announces NDA Acceptance for Zemprocitinib by NMPA

SHANGHAI, HANGZHOU, China and BOSTON, April 10, 2026 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. ("Lynk Pharmaceuticals"), a clinical-stage innovative drug development company focused on therapies for immune and inflammatory diseases, today announced that the New Drug Application (NDA) for its...

2026-04-10 08:00 7613

Oricell Therapeutics Closes $110 Million Pre-IPO Financing to Accelerate Global Development of Solid Tumor CAR-T Therapies

SHANGHAI, April 9, 2026 /PRNewswire/ -- Oricell Therapeutics Holdings Limited ("Oricell"), a global clinical-stage biotechnology company pioneering innovative cancer immunotherapies,today announced the cumulative closing of a pre-IPO financing round in excess of $110 million. The round was co-led...

2026-04-10 08:00 5245

FDA Accepts NDA for TLX101-Px (Pixclara®)

MELBOURNE, Australia and INDIANAPOLIS, April 10, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces that the United States (U.S.) Food and Drug Administration (FDA) has accepted the Company's resubmitted New Drug Application (NDA) for TLX101-Px[1],...

2026-04-10 06:50 6353

NEXTBIOMEDICAL Secures Exclusive Distribution Agreement for Nexsphere-F™ in Japan

SEOUL, South Korea, April 9, 2026 /PRNewswire/ -- NEXTBIOMEDICAL CO., LTD. (KOSDAQ: 389650), an innovative medical device company based in South Korea, announced today that it has entered into an exclusive distribution agreement in Japan with Asahi Intecc Co., Ltd., a global medical device compan...

2026-04-09 21:00 4922

Gan & Lee Pharmaceuticals Signs Exclusive License Agreement with JW Pharmaceutical, the Leading South Korean Pharma, to Advance the Global Commercialization of the Innovative GLP-1 Receptor Agonist Bofanglutide

BEIJING and BRIDGEWATER, N.J., April 9, 2026 /PRNewswire/ -- Gan & Lee Pharmaceuticals (hereinafter referred to as "Gan & Lee", SSE: 603087) announced the signing of an exclusive licensing agreement with JW Pharmaceutical, a leading pharmaceutical company in South Korea. Under the agreement, the ...

2026-04-09 21:00 6536

Gan & Lee Pharmaceuticals Signs Exclusive License Agreement with JW Pharmaceutical, the Leading South Korean Pharma, to Advance the Global Commercialization of the Innovative GLP-1 Receptor Agonist Bofanglutide

Nancy L. Lewis, MD, MBS, FACP, Named New Chief Scientific Officer for National Comprehensive Cancer Network (NCCN)

Accomplished medical research leader will oversee NCCN programs to advance clinical trials and improve the quality, effectiveness, and accessibility of cancer care. PLYMOUTH MEETING, Pa., April 9, 2026 /PRNewswire/ -- Today, the National Comprehensive Cancer Network® (NCCN®)—an alliance of leadi...

2026-04-09 20:03 5137

Nancy L. Lewis, MD, MBS, FACP, Named New Chief Scientific Officer for National Comprehensive Cancer Network (NCCN)

GenScript and Mimulus Partner to Industrialize DNA-Based Data Storage for the AI Era

The multi-year collaboration aims to scale molecular data storage infrastructure and unlock breakthrough cost efficiencies by 2030. PISCATAWAY, N.J. and LOS ANGELES, April 9, 2026 /PRNewswire/ -- GenScript Biotech Corporation, the world's leading provider of CMOS-based DNA synthesis technologies...

2026-04-09 20:00 4783

GenScript and Mimulus Partner to Industrialize DNA-Based Data Storage for the AI Era

DualityBio Announces China NMPA Acceptance of Biologics License Application Seeking Approval for Trastuzumab Pamirtecan for the Treatment of Unresectable or Metastatic HER2-Positive Adult Breast Cancer

SHANGHAI, April 9, 2026 /PRNewswire/ -- DualityBio ("DualityBio" or the "Company", Stock Code: 9606.HK) today announced that the Biologics License Application (BLA) for the investigational antibody-drug conjugate ("ADC") trastuzumab pamirtecan ("T-Pam", also known as DB-1303 or BNT323), has been ...

2026-04-09 19:55 5885

Terra Quantum AG to go public in $3.25 billion SPAC deal

Strategic go-public transaction aims to accelerate growth in quantum technologies and expand global market reach ST. GALLEN, Switzerland and INCLINE VILLAGE, Nev. , April 9, 2026 /PRNewswire/ -- Terra Quantum AG ("Terra Quantum"), a leading quantum technology company, and Mountain Lake Acquisiti...

2026-04-09 19:16 3709

Terra Quantum AG to go public in $3.25 billion SPAC deal

OncoC4 announces first participant's dosing in Phase 1/2 clinical trial of ONC-841 for the treatment of Alzheimer's disease

ROCKVILLE, Md., April 9, 2026 /PRNewswire/ -- OncoC4 Inc., a late clinical stage biopharmaceutical company, today announced first participant's dosing following the clearance of the Investigational New Drug (IND) application for a Phase 1/2 clinical trial of ONC-841, the company's investigational...

2026-04-09 19:00 5286

Kelun-Biotech Approved by HKEX to Remove "B" Marker from Stock Code, Representing a New Stage of Development

CHENGDU, China, April 9, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company", 6990.HK) today announced that following an application to The Stock Exchange of Hong Kong Limited (the "Stock Exchange") pursuant to Rule 18A.12 of the Rules Governin...

2026-04-09 18:33 5508

World's First CAR-T Therapy for Solid Tumors Available in China Soon

A New Hope for Patients with Advanced Gastric and Pancreatic Cancers SHANGHAI, April 9, 2026 /PRNewswire/ -- A groundbreaking new CAR-T cell therapy for advanced gastrointestinal cancers is expected to become available in China in the first half of 2026, marking a major step forward in cancer tr...

2026-04-09 18:09 4078

Taiwan-Based Towards Buddha Co., Ltd. Showcases Medical-Grade TPU Tubing Injection Solutions at Medtec Japan 2026

TAINAN, April 9, 2026 /PRNewswire/ -- Towards Buddha Co., Ltd., a Taiwan-based manufacturer of medical-grade plastic components, will exhibit at Medtec Japan 2026 this April, presenting its integrated TPU tubing injection manufacturing solutions in collaboration with ICP DAS BMP, a supplier of h...

2026-04-09 15:19 4514

World's First CAR-T Therapy for Solid Tumors Available in China Soon

A New Hope for Patients with Advanced Gastric and Pancreatic Cancers SHANGHAI, April 9, 2026 /PRNewswire/ -- A groundbreaking new CAR-T cell therapy for advanced gastrointestinal cancers is expected to become available in China in the first half of 2026, marking a major step forward in cancer tr...

2026-04-09 13:36 3744

World's First CAR-T Therapy for Solid Tumors Available in China Soon

A New Hope for Patients with Advanced Gastric and Pancreatic Cancers SHANGHAI, April 9, 2026 /PRNewswire/ -- A groundbreaking new CAR-T cell therapy for advanced gastrointestinal cancers is expected to become available in China in the first half of 2026, marking a major step forward in cancer tr...

2026-04-09 13:28 3917

Manulife Partners with Mind HK to Establish New Wellbeing Consultation Hub in Mong Kok

Free one-on-one, in-person mental health consultations to enhance community access to timely psychological support HONG KONG, April 9, 2026 /PRNewswire/ -- Manulife Hong Kong ("Manulife") today announced an expansion of its long‑standing partnership with its strategic charity partner Mind HK, wi...

2026-04-09 12:30 4065

Manulife Partners with Mind HK to Establish New Wellbeing Consultation Hub in Mong Kok

Shaklee Announces Appointment of New General Manager for Australia and New Zealand

MIAMI, April 9, 2026 /PRNewswire/ -- Shaklee, a global leader in health and wellness, announced the appointment of Bianca Cosentino as General Manager of Shaklee Australia and New Zealand, effective March 26th, 2026. Bianca bring...

2026-04-09 09:20 3382